Document:

<PAGE>

                                                                   EXHIBIT 10.53

                           CRITICAL THERAPEUTICS, INC.

                      2006 SALARIES FOR EXECUTIVE OFFICERS

      On November 30, 2005, based on the recommendation of the Compensation
Committee of the Board of Directors, our independent directors of the Board
approved market-adjustment and merit increases in the annual base salary of our
executive officers effective January 1, 2006. The 2006 annual base salary for
each of our executive officers will be as follows:

<TABLE>
<CAPTION>
Executive Officer                 Title                                                    2006 Annual Base Salary
-----------------                 -----                                                    -----------------------
<S>                               <C>                                                      <C>
Paul D. Rubin, M.D.               President and Chief Executive Officer                    $               367,000

Frederick Finnegan                Senior Vice President of Sales and Marketing             $               252,600

Walter Newman, Ph.D.              Chief Scientific Officer and Senior Vice President of    $               269,500
                                  Research and Development

Trevor Phillips, Ph.D.            Chief Operating Officer and Senior Vice President of     $               269,000
                                  Operations

Frank E. Thomas                   Chief Financial Officer, Senior Vice President of        $               252,600
                                  Finance and Treasurer

Scott B. Townsend, Esq.           Vice President of Legal Affairs and Secretary            $               220,000
</TABLE><PAGE>
                                                                   EXHIBIT 10.54

                           CRITICAL THERAPEUTICS, INC.

               MAXIMUM ANNUAL CASH BONUSES FOR EXECUTIVE OFFICERS

      On November 30, 2005, based on the recommendation of the Compensation
Committee of our Board of Directors, our independent directors of the Board
approved increases in the maximum annual cash bonuses payable to our executive
officers. Effective January 1, 2006, each executive officer will be eligible for
an annual maximum cash bonus for 2006 and each subsequent year of 30% of annual
base salary (previously eligible for 25% of annual base salary), or 45% of
annual base salary (previously eligible for 40% of annual base salary) for Dr.
Rubin, our chief executive officer, the amount of such bonus, if any, as
determined by the Compensation Committee. The Compensation Committee may make
actual cash bonus awards that may be greater or less than the annual maximum
cash bonus based on overall corporate performance and individual performance.
None of our executive officers is guaranteed any annual cash bonus.exv10w01

 

Exhibit 10.01

FIRST AMENDMENT TO THE FISHER SCIENTIFIC INTERNATIONAL INC.

DEFERRED COMPENSATION PLAN FOR

NON-EMPLOYEE DIRECTORS

The Board of Directors of Fisher Scientific International Inc. hereby amends the Fisher Scientific
International Inc. Deferred Compensation Plan for Non-Employee Directors (the “Plan”), effective as
of March 1, 2006, as follows:

	1.	 	The second sentence of Subparagraph 2(a) is hereby amended by replacing the word “as” with
the word “was.”
	 
	2.	 	The first paragraph of Section 3 is hereby amended by adding the following sentence thereto,
which shall be inserted after the first sentence of such Section:

“Such amounts shall be denominated in cash or in shares of the Corporation’s common stock
(“Shares”), in accordance with the Director’s election.”

	3.	 	The last sentence of the first paragraph of Section 3 is hereby restated in its entirety, as
follows:

“The Director shall not have any interest in the amounts or Shares credited to his account until
they are distributed in accordance with the Plan.”

	4.	 	The first sentence of the second paragraph of Section 3 is amended by inserting the words
“and denominated in cash” between the words “to the Director’s account” and “shall accrue
amounts” therein.
	 
	5.	 	A new third paragraph is hereby added to Section 3, as follows:

“Amounts credited to the Director’s account and denominated in Shares shall be determined by
dividing the amount of the deferred compensation elected to be deferred in the form of Shares by
the closing price of the Shares on the New York Stock Exchange on the last trading day of the
calendar quarter with respect to which such compensation is payable (with any fractional amounts
being denominated in cash). No interest shall accrue with respect to amounts deferred in Shares.
Any cash dividends and/or special dividends and distributions with respect to such shares shall be
credited to the Director’s account in cash.

	6.	 	Subparagraphs 4(a) and 4(b) of the Plan are hereby amended by adding the words “or Shares”
between the words “amount of cash” and “credited to the” in the first sentence of each such
subparagraph.
	 
	7.	 	Paragraph 5 of the Plan is hereby re-titled “DISTRIBUTION ON DEATH.”
	 
	8.	 	Subparagraph 6(b) of the Plan is hereby amended by adding the words “or Shares” between the
words “set aside funds” and “for the payment” therein.

1

 

	9.	 	Subparagraph 6(d) of the Plan is hereby amended by adding the words “of cash or Shares”
between the words “with respect to amounts” and “then in the Director’s account” therein.
	 
	10.	 	Subparagraph 6(e) of the Plan is hereby amended by adding the words “of cash or Shares”
between the words “indicating the amount” and “credited to the” therein.

2exv10w02

 

Exhibit 10.02

RETIREMENT PLAN FOR NON-EMPLOYEE DIRECTORS OF

FISHER SCIENTIFIC INTERNATIONAL INC.

Amendment

Fisher Scientific International Inc., a Delaware corporation, having heretofore adopted the
Retirement Plan for Non-Employee Directors of Fisher Scientific International Inc. (the “Plan”),
and having reserved the right under Section 6(c) thereof to amend the Plan, does hereby amend the
Plan, effective March 1, 2006, as set forth below:

Section 1 is hereby amended by adding the following sentence to the end thereof:

Notwithstanding anything herein to the contrary, upon the occurrence
of a Change in Control (as such term is defined in the Fisher
Scientific International Inc. 2005 Equity and Incentive Plan as in
effect on March 1, 2006), any member of the Board of the Corporation
or it subsidiaries who is not an employee of the Corporation and
then has less than five years of Eligible Service shall, for the
purposes of calculating Eligible Service, be deemed to have served
as a non-employee director on the Board for five years, and
thereafter, be deemed to have served as a non-employee director on
the Board for the greater of (i) five years or (ii) the actual
number of years he served as a non-employee director on the Board,
and shall be treated as an Eligible Director for all purposes of the
Plan.NUMBER                                                   SHARES

______C

                         JAGUAR ACQUISITION CORPORATION

              INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE

                                  COMMON STOCK

                                                                 SEE REVERSE FOR
                                                             CERTAIN DEFINITIONS

THIS CERTIFIES THAT                                    CUSIP

IS THE OWNER OF

FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $.0001 EACH OF THE
COMMON STOCK OF

                         JAGUAR ACQUISITION CORPORATION

transferable on the books of the Corporation in person or by duly authorized
attorney upon surrender of this certificate properly endorsed. The Corporation
will be forced to liquidate if it is unable to complete a business combination
within 18 months from the consummation of its initial public offering (or 24
months if certain extension criteria have been satisfied), all as more fully
described in the Corporation's final prospectus. This certificate is not valid
unless countersigned by the Transfer Agent and registered by the Registrar.
Witness the facsimile seal of the Corporation and the facsimile signatures of
its duly authorized officers.

     Dated:

                      (JAGUAR ACQUISITION CORPORATION LOGO)
-------------------------                              -------------------------
CHAIRMAN                                               SECRETARY

     The following abbreviations, when used in the inscription on the face of
this certificate, shall be construed as though they were written out in full
according to applicable laws or regulations:

     TEN COM -  as tenants in common               UNIF GIFT MIN ACT - _____ Custodian ______
     TEN ENT -  as tenants by the entireties                           (Cust)          (Minor)
     JT TEN -   as joint tenants with right of survivorship            under Uniform Gifts to Minors
                and not as tenants in common                           Act ______________
                                                                              (State)

     Additional Abbreviations may also be used though not in the above list.

                         JAGUAR ACQUISITION CORPORATION

     The Corporation will furnish without charge to each stockholder who so
requests the powers, designations, preferences and relative, participating,
optional or other special rights of each class of stock or series thereof of the
Corporation and the qualifications, limitations, or restrictions of such
preferences and/or rights. This certificate and the shares represented thereby
are issued and shall be held subject to all the provisions of the Certificate of
Incorporation and all amendments thereto and resolutions of the Board of
Directors providing for the issue of shares of Preferred Stock (copies of which
may be obtained from the secretary of the Corporation), to all of which the
holder of this certificate by acceptance hereof assents.

     For value received, ___________________________ hereby sell, assign and
transfer unto

PLEASE INSERT SOCIAL SECURITY OR OTHER
    IDENTIFYING NUMBER OF ASSIGNEE
--------------------------------------

--------------------------------------

--------------------------------------------------------------------------------
 (PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------
                                                                          shares
-------------------------------------------------------------------------

of the capital stock represented by the within Certificate, and do hereby
irrevocably constitute and appoint

                                                                        Attorney
-----------------------------------------------------------------------
to transfer the said stock on the books of the within named Corporation will
full power of substitution in the premises.

Dated
      ------------------------

                                   ---------------------------------------------
                                   NOTICE: The signature to this assignment must
                                           correspond with the name as written
                                           upon the face of the certificate in
                                           every particular, without alteration
                                           or enlargement or any change
                                           whatever.

Signature(s) Guaranteed:

--------------------------------------------------------------------------------
THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION
(BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH
MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO
S.E.C. RULE 17Ad-15).

The holder of this certificate shall be entitled to receive funds from the trust
fund only in the event of the Company's liquidation upon failure to consummate a
business combination or if the holder seeks to convert his respective shares
into cash upon a business combination which he voted against and which is
actually completed by the Company. In no other circumstances shall the holder
have any right or interest of any kind in or to the trust fund.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}]]